Grand Junction, Colorado Clinical Trials

A listing of Grand Junction, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the growth of tumor cells by blocking some of the enzymes …

vismodegib
tumor cells
gsk2256098
Grand Valley Oncology
 (1.0 away) Contact site
  • 4 views
  • 25 Jul, 2022
  • +510 other locations
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

This phase II trial compares the effect of oxybutynin versus placebo for reducing hot flashes in men receiving androgen deprivation (hormone) therapy for the treatment of prostate cancer . Androgen deprivation therapy decreases testosterone and other androgens through medications or surgical removal of the testicles. Relative to placebo, low- or …

Grand Valley Oncology
 (1.0 away) Contact site
  • 5 views
  • 26 Jul, 2022
  • +87 other locations
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

This phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating patients with endometrial cancer that has come back (recurrent) or does not respond to treatment (refractory). Olaparib, cediranib, and capivasertib may stop the growth of …

neutrophil count
non-target
serous adenocarcinoma
carcinoma
plain x-ray
Saint Mary's Hospital and Regional Medical Center
 (1.0 away) Contact site
  • 122 views
  • 26 Jul, 2022
  • +471 other locations
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)

In this observational study researcher want to learn more about the effectiveness of drug VITRAKVI (generic name: larotrectinib) and how well the drug is tolerated during routine use in patients with TRK fusion cancer which is locally advanced or spread from the place where it started to other places in …

SCL Health
 (0.8 away) Contact site
  • 50 views
  • 10 Jul, 2022
  • +51 other locations
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as well as harms associated with the MILD procedure, at 24 months post-treatment with MILD, tested against a control group of similar patients that have had a comparable procedure. This study …

Redlands Mesa Surgery Center
 (3.9 away) Contact site
  • 14549 views
  • 22 Jul, 2022
  • +1160 other locations
Palbociclib in Real World Practice

This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.

advanced breast cancer
breast adenocarcinoma
palbociclib
breast cancer
adenocarcinoma
Colorado West Healthcare System, dba Community Hospital
 (3.9 away) Contact site
  • 2458 views
  • 24 Jul, 2022
  • +216 other locations
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201)

CASCADE-LUNG is an event-driven, multisite, prospective, observational, blood specimen collection study in the elevated-risk lung cancer screening population. The primary objective is to determine the sensitivity and specificity of the Delfi Lung Cancer ScreeningTest (DLCST).

lung cancer screening
ct scan
lung cancer
lung carcinoma
cancer
SCL Health Research Institute, St. Mary's
 (0.8 away) Contact site
  • 0 views
  • 09 Aug, 2022
  • +10 other locations
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS system in the treatment of Parkinson's disease. Additionally, the utilization of Guide XT (GXT) System when used as a planning tool for the programming of patients with the …

brain stimulation
St. Mary's Hospital and Medical Center
 (1.0 away) Contact site
  • 163 views
  • 28 Jul, 2022
  • +53 other locations